Among U.S. large-cap drugmakers, one name has clearly outrun the pack in 2026 so far. Merck (NYSE:MRK | MRK Price Prediction) ...

Amgen Inc announced an update on their ongoing clinical study. Claim 55% Off TipRanks. Unlock powerful investing tools with TipRanks Premium to make smarter, more confident invest ...

Shares of Merck and Amgen are posting positive gains Wednesday morning, lifting the Dow Jones Industrial Average into positive territory. Shares of Merck and Amgen have contributed to the blue-chip ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...

Investors rotated toward profitable drugmakers while personalized cancer-vaccine results energized biotechnology stocks.

TScan has told Fierce that its pipeline strategy remains unchanged despite Amgen walking away from a Crohn’s disease ...

The biotech raised its full-year revenue forecast to $38.2 billion–$39.4 billion after second-quarter revenue rose 10% to $10.1 billion ...

Shares of Amgen Inc. AMGN advanced 1.41% to $425.28 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.69% to 7,691.76 and Dow ...

Get all latest & breaking news on Amgen Inc. Watch videos, top stories and articles on Amgen Inc at moneycontrol.com.

Amgen Inc. experienced a cyber incident that involved the theft of patient information and proprietary data stored in cloud servers, it said in a filing Friday, the latest large healthcare company to ...

Amgen reached a $74 million settlement of a lawsuit accusing the biotechnology company of ​waiting too long to disclose that ...

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...